SA
Sign upLog In

Aprea Therapeutics, Inc. (APRE)

Financing Cash Flow

$36.89M

TTM · Period ending: · USD

APRE logo

APRE Financing Cash Flow

Latest reported$36.89M
APRE TTM Cash from Financing ($91.19M → $36.89M)
High-resolution chart · PNG

APRE financing cash flow history

Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.

Aprea Therapeutics, Inc. Financing Cash Flow — Trailing twelve months (TTM) (USD)
Period endingFinancing Cash Flow (USD)
36,885,952
39,208,538
4,640,238
933,073
573,978
168,039
14,821,895
14,687,490
14,688,645
14,709,705
5,139,990
5,238,516
5,822,963
5,822,963
682,973
2,244,489
1,747,012
1,747,012
1,747,012
86,970
9,141
130,567
160,090
85,728,681
85,719,540
85,786,940
91,190,071
61,986,807
61,986,807
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.